Westminster alumnus Deepak Singh appointed Vice President of Sales and Marketing at CN Bio

CN Bio is a leading Organ-on-a-chip (OOC) company based in Cambridge, that designs and manufactures chips to recreate three-dimensional human organs and tissues in laboratories. 
As per the press release announcing his appointment on CN Bio’s website, Deepak Singh’s appointment will support the company’s commercial development, international operations, product research and sales in global markets. With over 30 years of commercial experience within life sciences, Singh will now oversee CN Bio’s international scale-up operations for product and service sides of the business.

Throughout his career, Singh has provided leadership for high-performance sales and marketing teams, supporting the expansion of products and services into drug discovery, bioproduction, research and diagnostics markets. Prior to his new role at CN Bio, he was the Head of Global Commercial at Horizon Discovery, and the Vice President of Europe, Middle East, and Africa (EMEA) Operations at Pacific Biosciences. He also held senior-level sales and marketing positions at Affymetrix and the Genetic Analysis Unit of Applied Biosystems.

Talking about his appointment in the CN Bio press release, Singh said: “Having had extensive experience within the life science industry, I am excited by the possibilities of OOC technology, and how fast the potential of this technology is being realised. As evidenced by the recent FDA Modernization Act 2.0 legislation in the US, this is a very promising time for the technology, and I am looking forward to joining the CN Bio team to bring their cutting-edge systems to more researchers across the globe, to enable decision-making within drug discovery workflows to be made with more confidence and earlier than ever before.”

Find out more about Biological and Biomedical Science courses at the University of Westminster.